Optogenetics, recognized by the 2026 medicine Nobel, makes cells respond to light, including eye cells that normally relay ...

Optogenetic therapy, based on Nobel prize-winning science, involves turning nerve cells on and off using light ...

A gene therapy based on Nobel prize-winning science has partially restored sight in some blind patients, with a clinical ...

The Nobel Prize committee says that optogenetics will lay the foundations for a new era in neuroscience, while pharma ...

The underlying field was recognized this week when the 2026 Nobel Prize in Physiology or Medicine went to Karl Deisseroth, MD ...

At EURETINA 2026, Arshad Khanani, MD, FASRS, reviews sura-vec, 4D-150 and ixo-vec, 3 nAMD gene therapies in phase 3 with ...

The U.S. Food and Drug Administration today approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA), also known as ...

CRISPR is one of this generation’s most profound innovations, with the potential to fundamentally alter the realm of modern day diagnostics and medical treatment. Scientists can use the tool to make ...

Andelyn Biosciences ("Andelyn"), a leading US-based patient-focused cell and gene therapy Contract Development and ...

Forbes contributors publish independent expert analyses and insights. A patient in a late-stage gene editing trial for a rare heart condition died from fatal liver complications after receiving an ...